Search Market Research Report
CBD Pet Market Size, Share Global Analysis Report, 2026-2034
CBD Pet Market Size, Share, Growth Analysis Report By Type (CBD Oils & Tinctures, CBD Treats & Chews, CBD Capsules & Softgels, CBD Topicals, and Others), By Pet Type (Dogs, Cats, Horses, and Others), By Application (Anxiety & Stress Relief, Joint & Mobility Support, Pain Management, General Wellness, and Others), and By Region - Global Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2026-2034
Industry Insights
[235+ Pages Report] According to Facts & Factors, the global CBD Pet market size was estimated at USD 1.25 billion in 2025 and is expected to reach USD 4.85 billion by the end of 2034. The CBD Pet industry is anticipated to grow by a CAGR of 16.3% between 2026 and 2034. The CBD Pet Market is driven by increasing pet humanization, rising awareness of natural wellness solutions for pets, and growing acceptance of CBD for anxiety, joint health, and overall pet well-being.
Market Overview
The CBD Pet market encompasses a wide range of ingestible, topical, and supplement products formulated with cannabidiol (CBD), a non-psychoactive compound derived from industrial hemp specifically designed and marketed for companion animals (primarily dogs, cats, and horses). These products include CBD oils/tinctures (administered directly or mixed with food), treats/chews, capsules/softgels, balms/ointments for localized relief, and functional pet foods/supplements containing broad-spectrum or isolate CBD with THC levels below 0.3% (or 0.0% in stricter jurisdictions). The market focuses on pet-specific formulations (species-appropriate dosing, palatable flavors, no artificial additives), third-party lab testing for potency/purity, and claims centered around stress/anxiety reduction, joint mobility support, pain relief, seizure management, skin/coat health, and general wellness, while navigating varying national regulations on veterinary use of hemp-derived CBD.
Key Insights
- As per the analysis shared by our research analyst, the global CBD Pet market is estimated to grow annually at a CAGR of around 16.3% over the forecast period (2026-2034).
- In terms of revenue, the global CBD Pet market size was valued at around USD 1.25 billion in 2025 and is projected to reach USD 4.85 billion by 2034.
- The global CBD Pet market is projected to grow at a significant rate due to pet humanization trends, increasing owner willingness to spend on wellness products, and growing anecdotal & emerging clinical support for CBD in pet anxiety and joint health.
- Based on the Type, the CBD Oils & Tinctures segment accounted for the largest market share of around 45% in 2025, due to precise dosing flexibility, fast sublingual/oral absorption, and long-standing consumer preference as the “original” CBD format for pets.
- Based on the Pet Type, the Dogs segment accounted for the largest market share of around 78% in 2025, due to dogs being the most common companion animal and having the highest reported use cases for anxiety, mobility, and pain.
- Based on the Application, the Anxiety & Stress Relief segment accounted for the largest market share of around 40% in 2025, due to the most frequently cited reason pet owners give CBD to their animals (separation anxiety, thunderstorms, travel, vet visits).
- Based on region, North America was the leading revenue generator in 2025, with approximately 68% share, due to early legalization of hemp-derived CBD, high pet ownership rates, and mature e-commerce & pet specialty retail channels.
Growth Drivers
- Pet Humanization & Wellness Spending Boom
Pet owners increasingly view pets as family members (“fur babies”), leading to a higher willingness to spend on premium health & wellness products. CBD fits perfectly into this trend as a natural, non-pharmaceutical option for common issues like anxiety, joint stiffness, and recovery after activity.
A growing body of anecdotal evidence, veterinarian recommendations, and emerging preclinical/clinical studies supporting CBD safety and efficacy for separation anxiety, noise phobias, osteoarthritis, and atopic dermatitis in dogs and cats is building consumer confidence and repeat usage.
Restraints
- Regulatory Uncertainty & Veterinary Restrictions
CBD remains in a legal gray area in many countries, while hemp-derived CBD (<0.3% THC) is federally legal in the U.S., it is not FDA-approved for animals, leading to inconsistent state-level enforcement, limited veterinary guidance, and caution among some pet owners and professionals.
Concerns over accurate dosing, potential drug interactions (especially with NSAIDs or anti-seizure meds), and lack of large-scale, peer-reviewed safety/efficacy studies for long-term use continue to create hesitation among risk-averse pet owners.
Opportunities
- Expansion into New Pet Types & Functional Formats
Growing cat ownership and increasing interest in equine CBD (joint health, calming for competition/trailering) represent large untapped segments with fewer competitors than the dog market.
Development of palatable, species-specific formats (soft chews for cats, powders for horses, flavored oils) and condition-targeted lines (senior mobility, puppy calming, post-surgery recovery) allows brands to capture higher margins and subscription revenue.
Challenges
- Quality & Potency Consistency Issues
The CBD pet market still suffers from products with inaccurate labeling (over- or understated CBD content), presence of THC/heavy metals/pesticides, and lack of standardized testing, damaging category trust and triggering occasional recalls or enforcement actions.
Competition from other natural pet supplements (turmeric, glucosamine, omega-3s, melatonin, L-theanine) and prescription pharmaceuticals (gabapentin, trazodone, Apoquel) creates a crowded field where CBD must continuously prove differentiation and value.
Report Scope
Report Attribute |
Details |
Market Size 2025 |
USD 1.25 Billion |
Projected Market Size in 2034 |
USD 4.85 Billion |
CAGR Growth Rate |
16.3% CAGR |
Base Year |
2025 |
Forecast Years |
2026-2034 |
Key Market Players |
Honest Paws, Pet Releaf, Penelope’s Bloom, HolistaPet, King Kanine, and Others. |
Key Segment |
By Type, By Pet Type, By Application, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Market Segmentation
The CBD Pet market is segmented by Type, Pet Type, Application, and region.
Based on Type Segment, the CBD Pet market is divided into CBD Oils & Tinctures, CBD Treats & Chews, CBD Capsules & Softgels, CBD Topicals, and others. The most dominant segment is CBD Oils & Tinctures, which holds the largest share due to precise dosing control, fast absorption (sublingual/oral), ability to mix with food, and position as the most trusted “original” format among pet owners; it drives the market by generating the highest repeat purchase rate and serving as the gateway product for new users. The second most dominant is CBD Treats & Chews, growing fastest due to convenience, palatability, and appeal as a daily supplement; this segment contributes significantly through high volume and subscription potential.
Based on Pet Type Segment, the CBD Pet market is divided into Dogs, Cats, Horses, and others. The most dominant segment is Dogs, commanding the highest share because dogs are the most common companion animal, have the broadest reported use cases (anxiety, arthritis, seizures), and benefit from the largest marketing spend; it propels market expansion by driving the majority of unit sales. The second most dominant is Cats, growing rapidly due to rising cat ownership and increasing acceptance of CBD for feline anxiety and mobility; this segment advances the market by diversifying beyond canine-focused products.
Based on Application Segment, the CBD Pet market is divided into Anxiety & Stress Relief, Joint & Mobility Support, Pain Management, General Wellness, and others. The most dominant segment is Anxiety & Stress Relief, with the largest share owing to the most frequently cited reason owners give CBD to pets (separation anxiety, thunderstorms, vet visits, travel); it fuels market growth by supporting daily-use consumption patterns. The second most dominant is Joint & Mobility Support, especially for senior pets; this segment supports market development through chronic condition demand.
Recent Developments
- In early 2025, Honest Paws launched a new high-potency CBD soft chew line specifically formulated for large-breed dogs with joint support (glucosamine + MSM + 10 mg CBD per chew).
- In late 2024, Pet Releaf expanded its USDA Organic CBD pet tincture portfolio with a feline-specific calming formula using broad-spectrum CBD and chamomile.
- In mid-2024, Penelope’s Bloom received expanded national distribution in Petco stores across the U.S. for its full-spectrum CBD treats and oils.
Regional Analysis
- North America to dominate the global market
North America dominates the global CBD Pet market, driven by the earliest and broadest legalization of hemp-derived CBD for pets (U.S. 2018 Farm Bill, Canada full legalization), highest pet ownership rates, most mature pet specialty retail & e-commerce channels, and strongest consumer spending on premium pet wellness. The region benefits from consumer familiarity and willingness to try natural alternatives. The United States emerges as the overwhelmingly dominant country, with the largest number of CBD pet users, highest revenue from treats/oils/topicals, and leadership in innovation (Honest Paws, Pet Releaf, Penelope’s Bloom, HolistaPet), supported by widespread availability in Petco, PetSmart, Chewy, Amazon, and independent pet boutiques.
Europe holds the second position, with strong growth in the UK, Germany, and the Netherlands following novel food approvals and national hemp programs. The United Kingdom dominates as the key country, benefiting from high pet humanization and premium pet retail presence.
Asia Pacific is the fastest-growing region, led by legal progress in Thailand, Australia, and South Korea. Thailand dominates as the primary country, with early legalization and rapidly expanding domestic brands targeting urban pet owners.
Latin America grows steadily with regulatory openings. Mexico and Brazil are the leading countries, with Mexico benefiting from pet wellness trends in urban areas.
The Middle East & Africa region remains small but emerging in premium pet segments. Israel leads due to advanced veterinary research and export-oriented CBD pet production.
Competitive Analysis
The global CBD Pet market is dominated by players:
- Honest Paws
- Pet Releaf
- Penelope’s Bloom
- HolistaPet
- King Kanine
- Charlotte’s Web (pet line)
- Medterra Pets
- HempMy Pet
- Canna-Pet
- Lolahemp
The global CBD Pet market is segmented as follows:
By Type
- CBD Oils & Tinctures
- CBD Treats & Chews
- CBD Capsules & Softgels
- CBD Topicals
- Others
By Pet Type
- Dogs
- Cats
- Horses
- Others
By Application
- Anxiety & Stress Relief
- Joint & Mobility Support
- Pain Management
- General Wellness
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Honest Paws
- Pet Releaf
- Penelope’s Bloom
- HolistaPet
- King Kanine
- Charlotte’s Web (pet line)
- Medterra Pets
- HempMy Pet
- Canna-Pet
- Lolahemp
Copyright © 2025 - 2026, All Rights Reserved, Facts and Factors